Metraipolis › archive › dc_ef57d4b44809

Clinical outcomes of cancer patients with pre-existing autoimmune thyroid disease treated with PD-(L)-1 inhibitors: a propensity score methodology with… — Europe PMC PMID:42369050

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42369050
DOI
10.3389/fendo.2026.1753280
License (as archived)
solo-consultazione
Archived
2026-10-31T14:05:39.924Z
SHA-256 of the archived text
6901efbedc86452ab0a24533cebc718fd9059b280136de7a6227bec341f39179
Stable URL of this page
https://metraipolis.com/documento/dc_ef57d4b44809

How to cite

Clinical outcomes of cancer patients with pre-existing autoimmune thyroid disease treated with PD-(L)-1 inhibitors: a propensity score methodology with… — Europe PMC PMID:42369050 — Europe PMC (en), https://europepmc.org/article/MED/42369050 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef57d4b44809 (Metraipolis archive dc_ef57d4b44809, sha256 6901efbedc86452ab0a24533cebc718fd9059b280136de7a6227bec341f39179)
BibTeX
@misc{dcef57d4b44809,
  title = {Clinical outcomes of cancer patients with pre-existing autoimmune thyroid disease treated with PD-(L)-1 inhibitors: a propensity score methodology with… — Europe PMC PMID:42369050},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42369050},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef57d4b44809; sha256 6901efbedc86452ab0a24533cebc718fd9059b280136de7a6227bec341f39179},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42369050. Agents can read the archived copy with the MCP tool read_document.